Matinas BioPharma Holdings, Inc
Price
FilingsNewest: 8-K, Change to holders' rightsSep 28 →InsidersNo open-market buys or sales.→HoldersRenaissance Technologies 1.1%BlackRock 0.8%Geode 0.8%→Financing →PeersClosest companies: RKTO, INDP, CRBP→
From the filings
Figures
- Net income
- −$6.7Mlast 12 months
- Operating cash flow
- −$6.6Mlast 12 months
- Cash and equivalents
- $761,000at the last balance sheet
- Shares outstanding
- 6.4M shareson issue